Skip to main content
DHR
NYSE Industrial Applications And Services

Danaher Reports Strong Q1 Earnings and Details Masimo Acquisition Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$195
Mkt Cap
$138.355B
52W Low
$180.03
52W High
$242.8
52W Position info
8.3% above low
Off High info
20% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DHR is trading near its 52-week low of $180.03 (8.3% above the low).

Summary

Danaher reported strong first-quarter financial results, including increased sales and diluted EPS, while also providing updates on the significant $9.9 billion Masimo acquisition and related financing activities.


Key Events · Earnings and Guidance · DHR

  • Strong Q1 Financial Performance

    Total sales increased by 3.5% to $5.95 billion for Q1 2026, with core sales growing by 0.5%. Diluted EPS rose to $1.45 from $1.32 in Q1 2025, and operating profit increased to $1.34 billion, improving operating profit margins to 22.6%.

  • Masimo Acquisition Update

    The company entered into a definitive agreement on February 16, 2026, to acquire Masimo Corporation for approximately $9.9 billion, including assumed indebtedness and net of acquired cash. The acquisition is expected to be financed using cash on hand and proceeds from debt.

  • New $5.0 Billion Credit Facility

    On April 16, 2026, Danaher secured a new $5.0 billion 364-day unsecured revolving credit facility. This facility is intended to provide additional liquidity support for commercial paper issuances and to fund a portion of the Masimo acquisition.

  • Significant Debt Repayment

    On March 18, 2026, the company repaid €1.3 billion (approximately $1.47 billion) aggregate principal amount of its 0.2% senior unsecured notes upon maturity, utilizing available cash and commercial paper proceeds.


Analysis · DHR · Industrial Applications And Services

Danaher Corporation's Q1 2026 results show a positive financial trajectory, with increased sales and diluted EPS compared to the prior year, a turnaround from the declining trend noted in the previous 10-K. The company's strategic focus is highlighted by the confirmed definitive agreement to acquire Masimo Corporation for approximately $9.9 billion, a significant transaction for the company. This acquisition is supported by a new $5.0 billion revolving credit facility, ensuring ample liquidity. Additionally, a substantial debt repayment further strengthens the balance sheet. Investors should monitor the integration of Masimo and the impact of the new credit facility on future financial performance.

At the time of this filing, DHR was trading at $195.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $138.4B. The 52-week trading range was $180.03 to $242.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DHR - Latest Insights

DHR
Jul 22, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $178.80
Real-time Price: $195.28 info
Change: +$16.48 (+9%) info
Market Cap: $137.279B info
DHR
Jul 21, 2026, 1:23 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $176.50
Real-time Price: $195.28 info
Change: +$18.78 (+11%) info
Market Cap: $137.279B info
DHR
Jul 21, 2026, 9:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $171.90
Real-time Price: $195.28 info
Change: +$23.38 (+14%) info
Market Cap: $137.279B info
DHR
Jul 21, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $184.00
Real-time Price: $195.28 info
Change: +$11.28 (+6%) info
Market Cap: $137.279B info
DHR
Jul 21, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $201.51
Real-time Price: $195.28 info
Change: -$6.23 (-3%) info
Market Cap: $137.279B info